Scholarlink

<p>Avian influenza continues to be a major threat to poultry and public health. This study investigated the efficacy of a bivalent H9N2/H5N2 modified live virus (MLV) vaccine delivered through a sequential aerosol priming and drinking water boosting in chickens. We hypothesized that this vaccination strategy would induce robust protective immunity against both low pathogenic H9N2 and high pathogenic H5N1 avian influenza viruses. The results demonstrated that the bivalent MLV vaccine provided sterilizing immunity against homologous and antigenically drifted H9N2 virus challenges. While anti-H5 antibody responses after MLV vaccination were generally weak, a robust anti-N2 antibody response was observed. Notably, the bivalent MLV prime-boost group demonstrated 90% survival against a high-dose H5N1 HPAI challenge. These findings highlight the potential of this mass vaccination approach, utilizing aerosol delivery complemented by drinking water administration, as a convenient and cost-effective method for avian influenza control, particularly H9N2 and H5N1 HPAI.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Sequential aerosol and oral immunization with a bivalent H9N2/H5N2 vaccine protects against H5N1 and H9N2 avian influenza challenges

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月27日

查看全文
  • Flavio Cargnin Faccin,
  • L. Claire Gay,
  • Dikshya Regmi,
  • Robert Hoelzl,
  • Teresa D. Mejías,
  • Darrell Kapczynski,
  • Florian Krammer,
  • Daniel R. Perez

摘要

Avian influenza continues to be a major threat to poultry and public health. This study investigated the efficacy of a bivalent H9N2/H5N2 modified live virus (MLV) vaccine delivered through a sequential aerosol priming and drinking water boosting in chickens. We hypothesized that this vaccination strategy would induce robust protective immunity against both low pathogenic H9N2 and high pathogenic H5N1 avian influenza viruses. The results demonstrated that the bivalent MLV vaccine provided sterilizing immunity against homologous and antigenically drifted H9N2 virus challenges. While anti-H5 antibody responses after MLV vaccination were generally weak, a robust anti-N2 antibody response was observed. Notably, the bivalent MLV prime-boost group demonstrated 90% survival against a high-dose H5N1 HPAI challenge. These findings highlight the potential of this mass vaccination approach, utilizing aerosol delivery complemented by drinking water administration, as a convenient and cost-effective method for avian influenza control, particularly H9N2 and H5N1 HPAI.